Sonnet BioTherapeutics Holdings, Inc.
SONN · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $149 | $2,274 | $3,053 | $27,622 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $762 | $787 | $717 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,206 | $1,677 | $1,644 | $1,189 |
| Total Curr. Assets | $2,118 | $4,738 | $5,414 | $28,812 |
| Property Plant & Equip (Net) | $144 | $227 | $303 | $182 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $509 | $464 | $113 | $0 |
| Total NC Assets | $653 | $691 | $416 | $182 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,771 | $5,429 | $5,830 | $28,994 |
| Liabilities | – | – | – | – |
| Payables | $2,183 | $2,202 | $4,752 | $3,781 |
| Short-Term Debt | $84 | $146 | $52 | $95 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $19 | $166 | $516 |
| Other Curr. Liab. | $942 | $3,158 | $3,194 | $2,310 |
| Total Curr. Liab. | $3,210 | $5,525 | $8,165 | $6,703 |
| LT Debt | $47 | $131 | $204 | $31 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $47 | $131 | $204 | $31 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $131 | $204 | $255 | $125 |
| Total Liabilities | $3,257 | $5,655 | $8,369 | $6,734 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $1 | $6 |
| Retained Earnings | -$117,681 | -$110,244 | -$91,411 | -$61,689 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $117,195 | $110,018 | $88,872 | $83,943 |
| Total Equity | -$486 | -$226 | -$2,539 | $22,260 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,771 | $5,429 | $5,830 | $28,994 |
| Net Debt | -$19 | -$1,997 | -$2,797 | -$27,496 |